Back to Search
Start Over
Comparison of clinical characteristics and overall survival between spirometrically diagnosed chronic obstructive pulmonary disease (COPD) and non-COPD never-smoking stage I-IV non-small cell lung cancer patients
- Source :
- International Journal of Chronic Obstructive Pulmonary Disease, The Lens
- Publication Year :
- 2019
- Publisher :
- Dove, 2019.
-
Abstract
- Jeong Uk Lim, Chang Dong Yeo, Chin Kook Rhee, Hye Seon Kang, Chan Kwon Park, Ju Sang Kim, Jin Woo Kim, Seung Joon Kim, Hyoung Kyu Yoon, Sang Haak LeeDivision of Pulmonology and Critical Care Medicine, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of KoreaObjectives: A significant proportion of non-small cell lung cancer (NSCLC) patients are never-smokers. However, the clinical impact of spirometrically diagnosed chronic obstructive pulmonary disease (COPD) on the prognosis of never-smoking NSCLC has not been evaluated in the context of treatment modalities and other cancer-related factors. In the present study, we evaluated the clinical impact of COPD in non-smoking NSCLC patients, and correlations between COPD and other previously unevaluated clinical variables.Materials and methods: Lung cancer patients (stages I to IV) diagnosed with NSCLC between January 2008 and December 2015 at six university hospitals were enrolled in the study cohort and retrospectively evaluated. Clinical parameters were compared between spirometrically diagnosed COPD and non-COPD groups. Correlations between COPD status and other variables were evaluated. In order to reduce the effect of potential confounders and selection bias, we performed adjustment for differences in baseline parameters by using propensity score matching (PSM). After PSM, clinical variables were evaluated for their effects on overall survival (OS).Results: Of the 345 patients enrolled in the study, 277 were categorized as non-COPD and 68 as COPD. Old age, male gender, and wild-type EGFR were significantly correlated with COPD. By univariate analysis of 218 patients in a propensity score matched cohort, not receiving active anticancer treatment, advanced stage, and COPD were significantly associated with shorter OS. Multivariate analysis showed that not receiving active anticancer treatment, advanced cancer stage, and COPD (P=0.044, HR: 1.526, 95% CI: 1.012–2.300) were significant predictors of shorter OS.Conclusion: In the present study, never-smoker NSCLC patients with COPD had shorter OS times, compared to non-COPD never-smoker NSCLC patients.Keywords: never smoker, overall survival, risk factor &nbsp
- Subjects :
- Adult
Male
medicine.medical_specialty
Lung Neoplasms
Time Factors
overall survival
Context (language use)
International Journal of Chronic Obstructive Pulmonary Disease
Risk Assessment
03 medical and health sciences
Pulmonary Disease, Chronic Obstructive
0302 clinical medicine
Predictive Value of Tests
Risk Factors
Internal medicine
Carcinoma, Non-Small-Cell Lung
Republic of Korea
medicine
Humans
030212 general & internal medicine
Risk factor
Stage (cooking)
Lung cancer
Lung
Original Research
Aged
Neoplasm Staging
Retrospective Studies
Aged, 80 and over
Univariate analysis
COPD
Smokers
business.industry
General Medicine
Non-Smokers
Middle Aged
medicine.disease
Prognosis
respiratory tract diseases
030228 respiratory system
risk factor
Spirometry
Cohort
Propensity score matching
Female
never smoker
business
Subjects
Details
- Language :
- English
- ISSN :
- 11782005 and 11769106
- Volume :
- 14
- Database :
- OpenAIRE
- Journal :
- International Journal of Chronic Obstructive Pulmonary Disease
- Accession number :
- edsair.doi.dedup.....d83a711aa2d866e762d7ea71dc1d9a08